These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. MMAC1/PTEN inhibits cell growth and induces chemosensitivity to doxorubicin in human bladder cancer cells. Tanaka M, Koul D, Davies MA, Liebert M, Steck PA, Grossman HB. Oncogene; 2000 Nov 09; 19(47):5406-12. PubMed ID: 11103942 [Abstract] [Full Text] [Related]
30. Evidence of a role for phosphatidylinositol 3-kinase activation in the blocking of apoptosis by polyomavirus middle T antigen. Dahl J, Jurczak A, Cheng LA, Baker DC, Benjamin TL. J Virol; 1998 Apr 09; 72(4):3221-6. PubMed ID: 9525648 [Abstract] [Full Text] [Related]
31. Hepatitis B Virus X protein modulates the expression of PTEN by inhibiting the function of p53, a transcriptional activator in liver cells. Chung TW, Lee YC, Ko JH, Kim CH. Cancer Res; 2003 Jul 01; 63(13):3453-8. PubMed ID: 12839924 [Abstract] [Full Text] [Related]
32. Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Guy CT, Muthuswamy SK, Cardiff RD, Soriano P, Muller WJ. Genes Dev; 1994 Jan 01; 8(1):23-32. PubMed ID: 7507074 [Abstract] [Full Text] [Related]
33. Loss of tumor suppressor p53 decreases PTEN expression and enhances signaling pathways leading to activation of activator protein 1 and nuclear factor kappaB induced by UV radiation. Wang J, Ouyang W, Li J, Wei L, Ma Q, Zhang Z, Tong Q, He J, Huang C. Cancer Res; 2005 Aug 01; 65(15):6601-11. PubMed ID: 16061640 [Abstract] [Full Text] [Related]
34. Enhanced tumor suppression by adenoviral PTEN gene therapy combined with cisplatin chemotherapy in small-cell lung cancer. Li D, Zhang Y, Xie Y, Xiang J, Zhu Y, Yang J. Cancer Gene Ther; 2013 Apr 01; 20(4):251-9. PubMed ID: 23470565 [Abstract] [Full Text] [Related]
35. Evaluation of the combined effect of p53 codon 72 polymorphism and hotspot mutations in response to anticancer drugs. Vikhanskaya F, Siddique MM, Kei Lee M, Broggini M, Sabapathy K. Clin Cancer Res; 2005 Jun 15; 11(12):4348-56. PubMed ID: 15958617 [Abstract] [Full Text] [Related]
36. Antitumor efficacy of a novel class of non-thiol-containing peptidomimetic inhibitors of farnesyltransferase and geranylgeranyltransferase I: combination therapy with the cytotoxic agents cisplatin, Taxol, and gemcitabine. Sun J, Blaskovich MA, Knowles D, Qian Y, Ohkanda J, Bailey RD, Hamilton AD, Sebti SM. Cancer Res; 1999 Oct 01; 59(19):4919-26. PubMed ID: 10519405 [Abstract] [Full Text] [Related]
37. Adenovirus-mediated wild-type p53 gene expression radiosensitizes non-small cell lung cancer cells but not normal lung fibroblasts. Kawabe S, Munshi A, Zumstein LA, Wilson DR, Roth JA, Meyn RE. Int J Radiat Biol; 2001 Feb 01; 77(2):185-94. PubMed ID: 11236925 [Abstract] [Full Text] [Related]
38. The phosphatidylinositol 3-kinase/AKT signal transduction pathway plays a critical role in the expression of p21WAF1/CIP1/SDI1 induced by cisplatin and paclitaxel. Mitsuuchi Y, Johnson SW, Selvakumaran M, Williams SJ, Hamilton TC, Testa JR. Cancer Res; 2000 Oct 01; 60(19):5390-4. PubMed ID: 11034077 [Abstract] [Full Text] [Related]
39. Efficacy with a replication-selective adenovirus plus cisplatin-based chemotherapy: dependence on sequencing but not p53 functional status or route of administration. Heise C, Lemmon M, Kirn D. Clin Cancer Res; 2000 Dec 01; 6(12):4908-14. PubMed ID: 11156251 [Abstract] [Full Text] [Related]
40. SV40 T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors. Tzeng YJ, Zimmermann C, Guhl E, Berg B, Avantaggiati ML, Graessmann A. Oncogene; 1998 Apr 23; 16(16):2103-14. PubMed ID: 9572491 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]